A Randomized, Single blind, Prospective, Multi-center, Phase II, Clinical Study to Evaluate Efficacy and Safety of Three Different Topical Formulations in Subjects Suffering from Headache. - NI

Emami Ltd0 个研究点目标入组 90 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Diagnosed with Tension Type Headache as per the ICHD II criteria (History of Headache for >= 1 Year, having at least 2 days of headache in a month, and the headache lasts for >= 4 hours if untreated)
•2.Subjects using Local application like oil, ointment, balm etc. the treatment of the headache.
•3.Subjects not having severe Headache requiring continues medical management
•4.Subjects signing written informed consent and ready to comply with the protocol requirement

•1.Headache due to conditions like migraine, sinusitis, cold, fever or any other underlying disease
•2.History of surgery of the Head, Neck, Eyes, Ear, and Nose at least one year prior to recruitment in the study
•3.Subjects who use regular analgesics for headache relief
•4.Use of any other investigational drug within 1 month prior to randomization
•5.Subjects having uncontrolled diabetes mellitus, tuberculosis, HIV, Ischemic Heart Disease
•6.Subjects using oral contraceptives
•7.Known other active and serious medical or surgical disease
•8.Pregnancy & Lactation
•9.Known hypersensitivity to compounds similar to the trial drug.

发起方

Emami Ltd